AUROBINDO PHARMA LTD.
|
Market Cap.(`)
|
64198.91 Cr.
|
P/BV
|
2.08
|
Book Value (`)
|
531.65
|
|
52 Week High/Low ( ` )
|
1592/1031
|
FV/ML
|
1/1
|
P/E(X)
|
20.23
|
|
Book Closure
|
29/08/2024
|
EPS (`)
|
54.63
|
Div Yield (%)
|
0.41
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 28704.50 | 24617.13 | 23366.55 | 24557.94 | 22737.96 |
| Other Operating Revenues | 297.37 | 238.25 | 88.94 | 216.68 | 360.55 |
| Total Operating Revenues | 29001.87 | 24855.38 | 23455.49 | 24774.62 | 23098.51 |
| | | | | | |
| Other Income | 557.38 | 290.59 | 320.35 | 380.85 | 191.87 |
| Total Revenue | 29559.25 | 25145.97 | 23775.84 | 25155.47 | 23290.38 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 10776.14 | 9652.51 | 7371.83 | 8317.26 | 7724.98 |
| Purchase Of Stock-In Trade | 2772.93 | 2050.43 | 1951.77 | 2315.42 | 2112.11 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -946.17 | -409.68 | 816.68 | -730.21 | -101.86 |
| Employee Benefit Expenses | 3922.94 | 3522.25 | 3450.92 | 3535.02 | 3219.18 |
| Finance Costs | 289.71 | 140.48 | 48.64 | 74.49 | 305.13 |
| Depreciation And Amortisation Expenses | 1521.66 | 1244.58 | 1126.52 | 1055.39 | 966.71 |
| Other Expenses | 6633.03 | 6321.23 | 5477.52 | 6003.73 | 5279.79 |
| Total Expenses | 24970.24 | 22521.80 | 20243.88 | 20571.10 | 19506.04 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 4589.01 | 2624.17 | 3531.96 | 4584.37 | 3784.34 |
| | | | | | |
| Exceptional Items | -191.86 | 0.00 | -127.97 | 2814.58 | -26.13 |
| Profit/Loss Before Tax | 4397.15 | 2624.17 | 3403.99 | 7398.95 | 3758.21 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1777.54 | 1071.48 | 662.82 | 2321.82 | 956.96 |
| Deferred Tax | -566.52 | -386.63 | 62.81 | -312.05 | -43.44 |
| Total Tax Expenses | 1211.02 | 684.85 | 725.63 | 2009.77 | 913.52 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 3186.13 | 1939.32 | 2678.36 | 5389.18 | 2844.69 |
| | | | | | |
| Profit/Loss From Continuing Operations | 3186.13 | 1939.32 | 2678.36 | 5389.18 | 2844.69 |
| | | | | | |
| Profit/Loss For The Period | 3186.13 | 1939.32 | 2678.36 | 5389.18 | 2844.69 |
| | | | | | |
| Minority Interest | 4.00 | -0.15 | 1.04 | 1.02 | 1.45 |
| Share Of Profit/Loss Of Associates | -17.16 | -11.67 | -31.25 | -55.36 | -15.17 |
| Consolidated Profit/Loss After MI And Associates | 3172.97 | 1927.50 | 2648.15 | 5334.84 | 2830.97 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 54.16 | 32.90 | 45.19 | 91.05 | 48.32 |
| Diluted EPS (Rs.) | 54.16 | 32.90 | 45.19 | 91.05 | 48.32 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 439.45 | 263.67 | 234.38 | 175.78 |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 12.79 |